ENTELLUS MED INC's ticker is ENTL and the CUSIP is 29363K105. A total of 83 filers reported holding ENTELLUS MED INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $23,000 | -8.0% | 950 | -28.8% | 0.00% | – |
| Q3 2017 | $25,000 | +108.3% | 1,334 | +90.6% | 0.00% | – |
| Q2 2017 | $12,000 | -42.9% | 700 | -52.9% | 0.00% | – |
| Q1 2017 | $21,000 | +5.0% | 1,486 | +40.7% | 0.00% | – |
| Q4 2016 | $20,000 | +25.0% | 1,056 | +50.9% | 0.00% | – |
| Q3 2016 | $16,000 | +23.1% | 700 | 0.0% | 0.00% | – |
| Q2 2016 | $13,000 | 0.0% | 700 | 0.0% | 0.00% | – |
| Q1 2016 | $13,000 | -18.8% | 700 | -26.3% | 0.00% | – |
| Q4 2015 | $16,000 | -5.9% | 950 | +1.5% | 0.00% | – |
| Q3 2015 | $17,000 | +13.3% | 936 | +59.2% | 0.00% | – |
| Q2 2015 | $15,000 | +650.0% | 588 | +488.0% | 0.00% | – |
| Q1 2015 | $2,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,956,456 | $54,577,000 | 41.39% |
| Discovery Group I, LLC | 2,089,974 | $38,581,000 | 14.72% |
| Essex Woodlands Management, Inc. | 3,231,656 | $59,656,000 | 10.58% |
| Archon Capital Management LLC | 550,224 | $10,157,000 | 5.46% |
| First Light Asset Management, LLC | 632,737 | $11,680,000 | 3.70% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 341,468 | $6,303,000 | 2.45% |
| Ghost Tree Capital, LLC | 561,510 | $10,365,000 | 2.20% |
| Aisling Capital LLC | 528,655 | $9,759,000 | 1.60% |
| Cypress Capital Management LLC (WY) | 66,965 | $1,236,000 | 1.46% |
| Endurant Capital Management LP | 208,771 | $3,854,000 | 1.17% |